SIRT6 and bladder transitional cell carcinoma: Furthermore, we knocked down UHRF1 in SIRT6-KD BLCA cells and observed that fast growth efficiency of SIRT6-deficient cells could be abrogated with UHRF1-KD treatment (Fig. 4D).